查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609545

術中神經監測市場規模、佔有率、趨勢分析報告：按產品、資訊來源、類型、地區和細分市場預測，2025-2030 年

Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Product, By Source, By Type, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

術中神經監測市場成長與趨勢：

2030年，全球術中神經監測市場規模預計將達到46.6億美元，預測期內複合年成長率為5.97%。

這一成長歸因於技術進步、設備安全意識增強以及老年人口不斷成長。 COVID-19 的爆發預計將對市場產生雙重影響。 2020 年 3 月，美國外科醫生學會 (ACS) 發表聲明，提案減少、延遲或取消擇期手術，因為美國的 COVID-19 病例迅速增加，預計這將阻礙成長。

此外，愛思唯爾雜誌（國際出血性中風協會；2021 年1 月）發表的一項研究發現，高達36% 的住院COVID-19 患者可能出現神經系統症狀，導致缺血性和出血性梗塞相關的病例有多例。此外，2021 年 6 月發表在 Neurology Online Journal 上的另一項最新研究表明，COVID-19 病毒可能與一種新的神經系統疾病的發展有關。新疾病的增加增加了院內死亡風險並降低了出院率。這些特徵預計將在預測期內帶來良好的成長。

此外，由於神經外科手術的數量和負擔能力不斷增加，以及手術期間對病人安全的日益重視，預計該市場將會成長。術中神經監測（IONM）已被醫院廣泛應用於手術中，因為它可以減少再次手術的次數以及術後併發症和後遺症的發生。

術中神經監測市場報告亮點

  • 按類型分類，2024 年，內資訊來源細分市場所佔佔有率最大，為 52.72%。這可能是由於患者和醫生對 IONM 益處的認知不斷提高，這導致醫院在複雜的手術中使用 IONM。這是IONM在該市場佔據主導地位的主要原因。
  • 按地區分類，北美地區佔比最大，2024年為49.35%。有利的報銷方案和技術進步是這項優勢的因素。
  • 歐洲術中神經監測市場預計在預測期內將以 6.38% 的複合年成長率快速成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 術中神經監測的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 術中神經監測分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章術中神經監測市場－細分分析，依產品，2018-2030

  • 術中神經監測市場：產品展望與要點
  • 術中神經監測市場：產品變異分析
  • 依產品
  • 系統
    • 2018-2030年系統市場收益估算與預測
  • 一次性的
    • 肌電圖管及電極
    • 貼紙電極
    • 刺激探針

第 5 章術中神經監測市場 – 細分分析（按資訊來源），2018-2030

  • 術中神經監測市場：資訊來源展望與要點
  • 術中神經監測市場：資訊來源波動分析
  • 資訊來源
  • 內源
    • 2018-2030年Insource市場收益估算與預測
  • 外包
    • 2018-2030年外包市場收益估算及預測

第6章術中神經監測市場－細分分析，依類型，2018-2030

  • 術中神經監測市場：類型展望與要點
  • 術中神經監測市場：類型變異分析
  • 按類型
  • 間歇監測
    • 2018-2030年間歇監測市場收益估計與預測
  • 持續監控
    • 2018-2030 年持續監測市場收益估算與預測

第7章術中神經監測市場：區域估計與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • Natus Medical Incorporated
    • Medtronic
    • Accurate Monitoring
    • Neuromonitoring Technologies
    • NuVasive, Inc.
    • SpecialtyCare, LLC
    • Neurosoft
    • Ambu A/S
    • Brainlab（Dr. Langer Medical GmbH）
    • Welcony（Neurosign UK Ltd.）
Product Code: GVR-1-68038-767-4

Intraoperative Neuromonitoring Market Growth & Trends:

The global intraoperative neuromonitoring market size is expected to reach USD 4.66 billion in 2030 and is anticipated to grow at a CAGR of 5.97% over the forecast period. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

Intraoperative Neuromonitoring Market Report Highlights:

  • By type, the insourced segment accounted for the largest share of 52.72% in 2024. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
  • By region, North America accounted for the largest share of 49.35% in 2024. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
  • The intraoperative neuromonitoring market in Europe is anticipated to grow fastest with a CAGR of 6.38% during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Source
    • 1.2.3. Type
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Intraoperative Neuromonitoring Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for IONM in hospitals
      • 3.2.1.2. Technological advancements in intraoperative neuromonitoring systems
      • 3.2.1.3. Increasing prevalence of neurovascular disorders
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
  • 3.3. Intraoperative Neuromonitoring Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Intraoperative Neuromonitoring Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. Intraoperative Neuromonitoring Market: Product Outlook and Key Takeaways
  • 4.2. Intraoperative Neuromonitoring Market: Product Movement Analysis
  • 4.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Product (USD Million)
  • 4.4. Systems
    • 4.4.1. Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Disposables
      • 4.5.1.1. Disposables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. EMG Tubes And Electrodes
      • 4.5.2.1. EMG Tubes And Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Sticker Electrode
      • 4.5.3.1. Sticker Electrode Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Stimulating Probes
      • 4.5.4.1. Stimulating Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intraoperative Neuromonitoring Market - Segment Analysis, by Source, 2018 - 2030 (USD Million)

  • 5.1. Intraoperative Neuromonitoring Market: Source Outlook and Key Takeaways
  • 5.2. Intraoperative Neuromonitoring Market: Source Movement Analysis
  • 5.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Source (USD Million)
  • 5.4. Insourced
    • 5.4.1. Insourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Outsourced
    • 5.5.1. Outsourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intraoperative Neuromonitoring Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 6.1. Intraoperative Neuromonitoring Market: Type Outlook and Key Takeaways
  • 6.2. Intraoperative Neuromonitoring Market: Type Movement Analysis
  • 6.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Type (USD Million)
  • 6.4. Intermittent Monitoring
    • 6.4.1. Intermittent Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Continuous Monitoring
    • 6.5.1. Continuous Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Intraoperative Neuromonitoring Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Natus Medical Incorporated
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Accurate Monitoring
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Neuromonitoring Technologies
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. NuVasive, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. SpecialtyCare, LLC
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Neurosoft
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Ambu A/S
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Brainlab (Dr. Langer Medical GmbH)
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Welcony (Neurosign UK Ltd.)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 6 U.S. intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 9 Canada intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 12 Mexico intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 15 Europe intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 19 Germany intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 22 UK intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 24 UK intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 25 France intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 26 France intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 27 France intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 28 Italy intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 30 Italy intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 31 Spain intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 33 Spain intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 34 Denmark intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 36 Denmark intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 37 Sweden intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 39 Sweden intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 40 Norway intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 42 Norway intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 47 China intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 48 China intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 49 China intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 50 Japan intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 52 Japan intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 53 India intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 54 India intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 55 India intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 56 South Korea intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 59 Australia intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 61 Australia intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 62 Thailand intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 64 Thailand intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 65 Latin America intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 66 Latin America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 67 Latin America intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 68 Brazil intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 71 Argentina intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 74 MEA intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 78 South Africa intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 84 UAE intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
  • Table 87 Kuwait intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Intraoperative neuromonitoring market segmentation
  • Fig. 2. Market research process
  • Fig. 3. Information procurement
  • Fig. 4. Primary research pattern
  • Fig. 5. Value chain based sizing & forecasting
  • Fig. 6. Market formulation & validation
  • Fig. 7. Market snapshot (global and regional)
  • Fig. 8. Product type & application segment snapshot
  • Fig. 9. Source segment snapshot
  • Fig. 10. Competitive landscape snapshot
  • Fig. 11. Porter's five forces analysis
  • Fig. 12. PESTLE analysis
  • Fig. 13. Intraoperative neuromonitoring market: Product outlook and key takeaways
  • Fig. 14. Intraoperative neuromonitoring market: Product movement analysis
  • Fig. 15. Intraoperative neuromonitoring market, for Systems, 2018 - 2030 (USD Million)
  • Fig. 16. Intraoperative neuromonitoring market, for Disposables, 2018 - 2030 (USD Million)
  • Fig. 17. Intraoperative neuromonitoring market, for EMG Tubes And Electrodes, 2018 - 2030 (USD Million)
  • Fig. 18. Intraoperative neuromonitoring market, for Sticker Electrode, 2018 - 2030 (USD Million)
  • Fig. 19. Intraoperative neuromonitoring market, for Stimulating Probes, 2018 - 2030 (USD Million)
  • Fig. 20. Intraoperative neuromonitoring market: Source outlook and key takeaways
  • Fig. 21. Intraoperative neuromonitoring market: Source movement analysis
  • Fig. 22. Intraoperative neuromonitoring market, for Insourced, 2018 - 2030 (USD Million)
  • Fig. 23. Intraoperative neuromonitoring market, for Outsourced, 2018 - 2030 (USD Million)
  • Fig. 24. Intraoperative neuromonitoring market: Type outlook and key takeaways
  • Fig. 25. Intraoperative neuromonitoring market: Type movement analysis
  • Fig. 26. Intraoperative neuromonitoring market, for Intermittent Monitoring, 2018 - 2030 (USD Million)
  • Fig. 27. Intraoperative neuromonitoring market, for Continuous Monitoring, 2018 - 2030 (USD Million)
  • Fig. 28. Regional marketplace: Key takeaways
  • Fig. 29. Regional marketplace: Key takeaways
  • Fig. 30. North America intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 31. U.S. intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 32. Key country dynamics
  • Fig. 33. Canada intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 34. Key country dynamics
  • Fig. 35. Mexico intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 36. Key country dynamics
  • Fig. 37. UK intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 38. Key country dynamics
  • Fig. 39. Germany intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 40. Key country dynamics
  • Fig. 41. France intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 42. Key country dynamics
  • Fig. 43. Italy intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 44. Key country dynamics
  • Fig. 45. Spain intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 46. Key country dynamics
  • Fig. 47. Sweden intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 48. Key country dynamics
  • Fig. 49. Denmark intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 50. Key country dynamics
  • Fig. 51. Norway intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 52. Key country dynamics
  • Fig. 53. Japan probes reprocessing market, 2018 - 2030 (USD Million)
  • Fig. 54. Key country dynamics
  • Fig. 55. China intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 56. Key country dynamics
  • Fig. 57. India intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 58. Key country dynamics
  • Fig. 59. Australia intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 60. Key country dynamics
  • Fig. 61. South Korea intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 62. Key country dynamics
  • Fig. 63. Thailand intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 64. Latin America intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 65. Key country dynamics
  • Fig. 66. Brazil intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 67. Key country dynamics
  • Fig. 68. Argentina intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 69. Key country dynamics
  • Fig. 70. South Africa intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 71. Key country dynamics
  • Fig. 72. Saudi Arabia intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 73. Key country dynamics
  • Fig. 74. UAE intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 75. Key country dynamics
  • Fig. 76. Kuwait intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
  • Fig. 77. Key company categorization
  • Fig. 78. Strategic framework